Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer

Cell Reports(2022)10.1016/j.celrep.2022.110417Source: DataRank Database

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

geo gen cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.00)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Nebiyou Y. Metaferia,Marina F. Nogueira ORCID,Sarah Abou Alaiwi ORCID,Ji-Heui Seo ORCID,Justin H. Hwang ORCID

Live enrichment

PubMed:35196489 PMC:PMC9036938 OpenAlex:https://openalex.org/W3036448612

NCI NIH HHS

Grant: K99 CA208028

NCI NIH HHS

Grant: R00 CA208028

NCI NIH HHS

Grant: T32 CA009172

NCI NIH HHS

Grant: U01 CA176058

NCI NIH HHS

Grant: R01 CA193910

NCI NIH HHS

Grant: R01 CA204954

National Institutes of Health

Grant: 5R01CA193910-04

Defining the epigenetic landscape in human prostate cancer

National Institutes of Health

Grant: 5U01CA176058-09

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

National Institutes of Health

Grant: 5R01CA204954-04

Identifying causal variants and genes underlying breast cancer risk loci

National Institutes of Health

Grant: 5R00CA208028-04

Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis

FWCI

0.00

Citation Percentile

0.0%

Citation Trend

2021

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S2211124722001413/pdf

publisherhttp://www.cell.com/article/S2211124722001413/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722001413?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722001413?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2022.110417

Fields of Study

Cancer-related gene regulationProstate Cancer Treatment and ResearchEpigenetics and DNA Methylation0301 basic medicine0303 health sciences03 medical and health sciencesAndrogen AntagonistsCell Line, TumorGene Expression Regulation, NeoplasticHumansMaleProstateProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantProtein-Arginine N-MethyltransferasesReceptors, AndrogenRepressor ProteinsSignal Transduction

MeSH Terms

Androgen AntagonistsHumansMaleProstateProstatic NeoplasmsProtein-Arginine N-MethyltransferasesReceptors, AndrogenRepressor ProteinsSignal TransductionGene Expression Regulation, NeoplasticCell Line, TumorProstatic Neoplasms, Castration-Resistant

Keywords

Androgen receptorProstate cancerCancer researchRegulatorBiologyAndrogen deprivation therapyAndrogenCRISPRSignal transductionCancerCell biologyEndocrinologyGeneticsGeneHormoneTranscriptionSplicingPrmt1SuperenhancerCrispr ScreenMaleProtein-Arginine N-MethyltransferasesProstateProstatic NeoplasmsAndrogen AntagonistsGene Expression Regulation, NeoplasticRepressor ProteinsProstatic Neoplasms, Castration-ResistantReceptors, AndrogenCell Line, TumorHumans

Sustainable Development Goals

SDG 3: 3. Good health